We are live on ! Find out more
AP

Atwood & Palmer Portfolio holdings

AUM $1.87B
1-Year Est. Return 24.22%
This Fund
S&P 500
This Quarter Est. Return
+4.23%
1 Year Est. Return
+24.22%
3 Year Est. Return
+82.33%
5 Year Est. Return
+97.89%
10 Year Est. Return
+352.71%
AUM
$1.12B
AUM Growth
+$54.5M
Cap. Flow
+$26.3M
Cap. Flow %
2.35%
Top 10 Hldgs %
29.48%
Holding
398
New
28
Increased
109
Reduced
39
Closed
2

Top Buys

Rank Stock Value
1
VRTX icon
Vertex Pharmaceuticals
VRTX
+$17.6M
2
PYPL icon
PayPal
PYPL
+$8.22M
3
GILD icon
Gilead Sciences
GILD
+$7.14M
4
REGN icon
Regeneron Pharmaceuticals
REGN
+$2.62M
5
AVEM icon
Avantis Emerging Markets Equity ETF
AVEM
+$2.36M

Top Sells

Rank Stock Value
1
AMGN icon
Amgen
AMGN
+$19.6M
2
URI icon
United Rentals
URI
+$6.93M
3
LMT icon
Lockheed Martin
LMT
+$2.69M
4
AAPL icon
Apple
AAPL
+$2.39M
5
VNLA icon
Janus Henderson Short Duration Income ETF
VNLA
+$805K

Sector Composition

Rank Sector Weight
1 Healthcare 18.15%
2 Technology 17.83%
3 Financials 12.37%
4 Industrials 9.95%
5 Consumer Discretionary 6.83%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
VFC icon
301
VF Corp
VFC
$5.8B
$13.4K ﹤0.01%
701
+200
+40% +$4.1K
NTAP icon
302
NetApp
NTAP
$37.6B
$13.4K ﹤0.01%
175
– –
ABNB icon
303
Airbnb
ABNB
$90B
$12.8K ﹤0.01%
100
– –
AFL icon
304
Aflac
AFL
$64.5B
$12.2K ﹤0.01%
175
– –
ARCC icon
305
Ares Capital
ARCC
$14.1B
$12.1K ﹤0.01%
643
– –
SYK icon
306
Stryker
SYK
$129B
$11.9K ﹤0.01%
39
– –
ULTA icon
307
Ulta Beauty
ULTA
$23.2B
$11.8K ﹤0.01%
25
– –
CNP icon
308
CenterPoint Energy
CNP
$26.8B
$11.7K ﹤0.01%
400
– –
FBT icon
309
First Trust NYSE Arca Biotechnology Index Fund
FBT
$2.74B
$11.5K ﹤0.01%
75
– –
MMM icon
310
3M
MMM
$93.2B
$11.4K ﹤0.01%
136
– –
F icon
311
Ford
F
$55B
$11.3K ﹤0.01%
+750
New +$9.49K
DKNG icon
312
DraftKings
DKNG
$11B
$10.6K ﹤0.01%
400
– –
SPR
313
DELISTED
Spirit AeroSystems
SPR
$10.2K ﹤0.01%
350
– –
EXC icon
314
Exelon
EXC
$46.7B
$10K ﹤0.01%
246
+46
+23% +$1.9K
PGR icon
315
Progressive
PGR
$125B
$9.93K ﹤0.01%
75
– –
UPS icon
316
United Parcel Service
UPS
$87.7B
$9.32K ﹤0.01%
52
+20
+63% +$3.55K
CORR
317
DELISTED
CorEnergy Infrastructure Trust, Inc.
CORR
$9.3K ﹤0.01%
8,300
– –
MET icon
318
MetLife
MET
$64.3B
$9.04K ﹤0.01%
160
– –
TXN icon
319
Texas Instruments
TXN
$254B
$9K ﹤0.01%
50
– –
VCR icon
320
Vanguard Consumer Discretionary ETF
VCR
$6.24B
$8.5K ﹤0.01%
30
– –
ACN icon
321
Accenture
ACN
$105B
$8.33K ﹤0.01%
27
– –
PACW
322
DELISTED
PacWest Bancorp
PACW
$8.15K ﹤0.01%
1,000
-2,000
-67% -$16.1K
MNKD icon
323
MannKind Corp
MNKD
$1.24B
$8.14K ﹤0.01%
2,000
– –
TXT icon
324
Textron
TXT
$15.1B
$8.12K ﹤0.01%
120
– –
TGT icon
325
Target
TGT
$66.8B
$8.05K ﹤0.01%
61
– –
11 12
13
14 15

Similar funds

PCP
Proficio Capital Partners Newton, Massachusetts $1.87B AUM 30.54% 1-Year Est. Return
JPG
Jordan Park Group San Francisco, California $1.88B AUM 16.2% 1-Year Est. Return
PCM
Portolan Capital Management Boston, Massachusetts $1.88B AUM 115.74% 1-Year Est. Return
EPW
Evolve Private Wealth Los Angeles, California $1.87B AUM
P3I
Progeny 3 Inc Kirkland, Washington $1.87B AUM 30.4% 1-Year Est. Return
LPU
Lansdowne Partners (UK) London, United Kingdom $1.87B AUM 61.55% 1-Year Est. Return
SGF
S&G Foundation Wilson, Wyoming $1.88B AUM
TF
Trek Financial Scottsdale, Arizona $1.88B AUM 41.21% 1-Year Est. Return

Atwood & Palmer's Q2 2023 Portfolio in Review

As of Q2 2023, Atwood & Palmer held 398 positions worth $1.12B, up 5.1% from $1.06B the previous quarter. Its ten largest holdings account for 29% of the portfolio.

Atwood & Palmer's Q2 2023 filing shows 28 new, 109 increased, 39 reduced and 2 closed positions. Its largest new stake was Vertex Pharmaceuticals: 52,175 shares worth $18.4M. The largest sale was Amgen, an estimated $19.6M.

By sector, the portfolio is most concentrated in Healthcare at 18% of assets, down from 19% a quarter earlier, followed by Technology and Financials.

  • Atwood & Palmer's largest Q2 2023 buy was Vertex Pharmaceuticals: 52,175 shares worth $18.4M.
  • Atwood & Palmer added most to PayPal in Q2 2023, an estimated $8.22M increase.
  • Atwood & Palmer's biggest Q2 2023 reduction was Amgen, cutting an estimated $19.6M.
  • Atwood & Palmer fully exited First Trust Materials AlphaDEX Fund in Q2 2023, selling an estimated $217K.
  • Atwood & Palmer's ten largest holdings make up 29% of its $1.12B portfolio in Q2 2023.
  • Atwood & Palmer opened 28 new positions and closed 2 in Q2 2023.
  • Atwood & Palmer's portfolio value rose 5.1% quarter-over-quarter to $1.12B.

Based on Atwood & Palmer's 13F filing for Q2 2023, filed 18 Jul 2023.